Cargando…
Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study
Parkinson’s disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-prote...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032099/ https://www.ncbi.nlm.nih.gov/pubmed/29848975 http://dx.doi.org/10.3390/ijms19061611 |
_version_ | 1783337439354421248 |
---|---|
author | Longhena, Francesca Faustini, Gaia Missale, Cristina Pizzi, Marina Bellucci, Arianna |
author_facet | Longhena, Francesca Faustini, Gaia Missale, Cristina Pizzi, Marina Bellucci, Arianna |
author_sort | Longhena, Francesca |
collection | PubMed |
description | Parkinson’s disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-protein interactions in tissues to detect dopamine transporter (DAT)/α-synuclein complexes, we previously described that these are markedly redistributed in the striatum of human α-synuclein transgenic mice at the phenotypic stage, showing dopamine (DA) release impairment without a DAT drop and motor symptoms. Here, we used the in situ PLA to investigate DAT/α-synuclein complexes in the caudate putamen of PD patients and age-matched controls. They were found to be redistributed and showed an increased size in PD patients, where we observed several neuropil-like and neuritic-like PLA-positive structures. In the PD brains, DAT immunolabeling showed a pattern similar to that of in situ PLA in areas with abundant α-synuclein neuropathology. This notwithstanding, the in situ PLA signal was only partially retracing DAT or α-synuclein immunolabeling, suggesting that a large amount of complexes may have been lost along with the degeneration process. These findings reveal a DAT/α-synuclein neuropathological signature in PD and hint that synaptic alterations involving striatal DAT may derive from α-synuclein aggregation. |
format | Online Article Text |
id | pubmed-6032099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60320992018-07-13 Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study Longhena, Francesca Faustini, Gaia Missale, Cristina Pizzi, Marina Bellucci, Arianna Int J Mol Sci Communication Parkinson’s disease (PD) is characterized by the degeneration of the dopaminergic nigrostriatal neurons and the presence of Lewy bodies (LB) and Lewy neurites (LN) mainly composed of α-synuclein. By using the in situ proximity ligation assay (PLA), which allows for the visualization of protein-protein interactions in tissues to detect dopamine transporter (DAT)/α-synuclein complexes, we previously described that these are markedly redistributed in the striatum of human α-synuclein transgenic mice at the phenotypic stage, showing dopamine (DA) release impairment without a DAT drop and motor symptoms. Here, we used the in situ PLA to investigate DAT/α-synuclein complexes in the caudate putamen of PD patients and age-matched controls. They were found to be redistributed and showed an increased size in PD patients, where we observed several neuropil-like and neuritic-like PLA-positive structures. In the PD brains, DAT immunolabeling showed a pattern similar to that of in situ PLA in areas with abundant α-synuclein neuropathology. This notwithstanding, the in situ PLA signal was only partially retracing DAT or α-synuclein immunolabeling, suggesting that a large amount of complexes may have been lost along with the degeneration process. These findings reveal a DAT/α-synuclein neuropathological signature in PD and hint that synaptic alterations involving striatal DAT may derive from α-synuclein aggregation. MDPI 2018-05-30 /pmc/articles/PMC6032099/ /pubmed/29848975 http://dx.doi.org/10.3390/ijms19061611 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Longhena, Francesca Faustini, Gaia Missale, Cristina Pizzi, Marina Bellucci, Arianna Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study |
title | Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study |
title_full | Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study |
title_fullStr | Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study |
title_full_unstemmed | Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study |
title_short | Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay Study |
title_sort | dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of parkinson’s disease: an in situ proximity ligation assay study |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032099/ https://www.ncbi.nlm.nih.gov/pubmed/29848975 http://dx.doi.org/10.3390/ijms19061611 |
work_keys_str_mv | AT longhenafrancesca dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy AT faustinigaia dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy AT missalecristina dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy AT pizzimarina dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy AT bellucciarianna dopaminetransporterasynucleincomplexesarealteredinthepostmortemcaudateputamenofparkinsonsdiseaseaninsituproximityligationassaystudy |